Epidemiology of type 1 diabetes and what animal models teach us about the role of viruses in disease mechanisms

Clinical Immunology

Volumn 131, Issue 1, 2009, Pages 11-23

  Zipris, Danny ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

Dendritic cell; Epidemiology; Innate immunity; Kilham rat virus; Toll like receptor; Type 1 diabetes; Virus

Indexed keywords

CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 24; INTERLEUKIN 6; INTERLEUKIN 8; STAT1 PROTEIN; STAT2 PROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

COXSACKIE VIRUS B; CYTOMEGALOVIRUS; ENVIRONMENTAL FACTOR; EPIDEMIC; EPSTEIN BARR VIRUS; GENETIC SUSCEPTIBILITY; HUMAN; INCIDENCE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; MUMPS VIRUS; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; RECEPTOR UPREGULATION; ROTAVIRUS; RUBELLA VIRUS; SHORT SURVEY; SIGNAL TRANSDUCTION; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

ANIMALS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HUMANS; INCIDENCE; VIRUS DISEASES;

EID: 63249107452     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.12.011     Document Type: Short Survey

References (171)

1. Srikanta S., Ganda O.P., Jackson R.A., Gleason R.E., Kaldany A., Garovoy M.R., Milford E.L., Carpenter C.B., Soeldner J.S., and Eisenbarth G.S. Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann. Intern. Med. 99 (1983) 320-326
2. Kyvik K.O., Nystrom L., Gorus F., Songini M., Oestman J., Castell C., Green A., Guyrus E., Ionescu-Tirgoviste C., McKinney P.A., Michalkova D., Ostrauskas R., and Raymond N.T. The epidemiology of Type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia 47 (2004) 377-384
3. Somoza N., Vargas F., Roura-Mir C., Vives-Pi M., Fernandez-Figueras M.T., Ariza A., Gomis R., Bragado R., Marti M., and Jaraquemada D. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J. Immunol. 153 (1994) 1360-1377
4. Gianani R., and Eisenbarth G.S. The stages of type 1A diabetes: 2005. Immunol. Rev. 204 (2005) 232-249
5. Imagawa A., Hanafusa T., Itoh N., Waguri M., Yamamoto K., Miyagawa J., Moriwaki M., Yamagata K., Iwahashi H., Sada M., Tsuji T., Tamura S., Kawata S., Kuwajima M., Nakajima H., Namba M., and Matsuzawa Y. Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset Type I (insulin-dependent) diabetes mellitus. Diabetologia 42 (1999) 574-578
6. Moriwaki M., Itoh N., Miyagawa J., Yamamoto K., Imagawa A., Yamagata K., Iwahashi H., Nakajima H., Namba M., Nagata S., Hanafusa T., and Matsuzawa Y. Fas and Fas ligand expression in inflamed islets in pancreas sections of patients with recent-onset Type I diabetes mellitus. Diabetologia 42 (1999) 1332-1340
7. Atkinson M.A., and Eisenbarth G.S. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358 (2001) 221-229
8. Bonifacio E., Lampasona V., Genovese S., Ferrari M., and Bosi E. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J. Immunol. 155 (1995) 5419-5426
9. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., and Paquette T.L. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222 (1983) 1337-1339
10. Baekkeskov S., Aanstoot H.J., Christgai S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., and Camilli P.D. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347 (1990) 151-156
11. Wenzlau J.M., Juhl K., Yu L., Moua O., Sarkar S.A., Gottlieb P., Rewers M., Eisenbarth G.S., Jensen J., Davidson H.W., and Hutton J.C. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 17040-17045
12. Silveira P.A., Serreze D.V., and Grey S.T. Invasion of the killer B's in type 1 diabetes. Front. Biosci. 12 (2007) 2183-2193
13. Crisa L., Mordes J.P., and Rossini A.A. Autoimmune diabetes mellitus in the BB rat. Diabetes/Metab. Rev. 8 (1992) 4-37
14. Rossini A.A., Handler E.S., Mordes J.P., and Greiner D.L. Human autoimmune diabetes mellitus: lessons from BB rats and NOD mice-Caveat emptor. Clin. Immunol. Immunopathol. 74 (1995) 2-9
15. Di Lorenzo T.P., Peakman M., and Roep B.O. Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes. Clin. Exp. Immunol. 148 (2007) 1-16
16. van de L.P., and Roep B.O. T-cell assays to determine disease activity and clinical efficacy of immune therapy in type 1 diabetes. Am. J. Ther. 12 (2005) 573-579
17. Roep B.O. The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure. Diabetologia 46 (2003) 305-321
18. Pinkse G.G., Tysma O.H., Bergen C.A., Kester M.G., Ossendorp F., van Veelen P.A., Keymeulen B., Pipeleers D., Drijfhout J.W., and Roep B.O. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18425-18430
19. Naik R.G., Beckers C., Wentwoord R., Frenken A., Duinkerken G., Brooks-Worrell B., Schloot N.C., Palmer J.P., and Roep B.O. Precursor frequencies of T-cells reactive to insulin in recent onset type 1 diabetes mellitus. J. Autoimmun. 23 (2004) 55-61
20. Nagata M., Kotani R., Moriyama H., Yokono K., Roep B.O., and Peakman M. Detection of autoreactive T cells in type 1 diabetes using coded autoantigens and an immunoglobulin-free cytokine ELISPOT assay: report from the fourth immunology of diabetes society T cell workshop. Ann. N.Y. Acad. Sci. 1037 (2004) 10-15
21. Durinovic-Bello I., Rosinger S., Olson J.A., Congia M., Ahmad R.C., Rickert M., Hampl J., Kalbacher H., Drijfhout J.W., Mellins E.D., Al Dahouk S., Kamradt T., Maeurer M.J., Nhan C., Roep B.O., Boehm B.O., Polychronakos C., Nepom G.T., Karges W., McDevitt H.O., and Sonderstrup G. DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 11683-11688
22. Herold K.C., Gitelman S.E., Masharani U., Hagopian W., Bisikirska B., Donaldson D., Rother K., Diamond B., Harlan D.M., and Bluestone J.A. A single course of Anti-CD3 monoclonal antibody hokt3{gamma}1(Ala-Ala) results in improvement in c-peptide responses and clinical parameters for at least 2 years after onset of type 1 Diabetes. Diabetes 54 (2005) 1763-1769
23. Lampeter E.F., Homberg M., Quabeck K., Schaefer U.W., Wernet P., Bertrams J., Grosse-Wilde H., Gries F.A., and Kolb H. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 341 (1993) 1243-1244
24. The DIAMOND Project Group. Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. Diabet. Med. 23 (2006) 857-866
25. Soltesz G., Patterson C., and Dahlquist G. Global trends in childhood type 1 diabetes. In: Gan D. (Ed). Diabetes Atlas (2006), International Diabetes Federation, Brusslels 153-190
26. Craig M.E., Howard N.J., Silink M., and Chan A. The rising incidence of childhood type 1 diabetes in New South Wales, Australia. J. Pediatr. Endocrinol. Metab. 13 (2000) 363-372
27. Yang Z., Wang K., Li T., Sun W., Li Y., Chang Y.F., Dorman J.S., and LaPorte R.E. Childhood diabetes in China. Enormous variation by place and ethnic group. Diabetes Care 21 (1998) 525-529
28. Yang Z., Long X., Shen J., Liu D., Dorman J.S., LaPorte R.E., and Chang Y.F. Epidemics of type 1 diabetes in China. Pediatr. Diabetes 6 (2005) 122-128
29. Green A., and Patterson C.C. Trends in the incidence of childhood-onset diabetes in Europe 1989-1998. Diabetologia 44 Suppl. 3 (2001) B3-B8
30. Eurodiab Ace Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet 355 (2000) 873-876
31. Karvonen M., Viik-Kajander M., Moltchanova E., Libman I., LaPorte R., and Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. diabetes mondiale (DiaMond) project group. Diabetes Care 23 (2000) 1516-1526
32. Newhook L.A., Curtis J., Hagerty D., Grant M., Paterson A.D., Crummel C., Bridger T., and Parfrey P. High Incidence of childhood Type 1 diabetes in the avalon peninsula, newfoundland, canada. Diabetes Care 27 (2004) 885-888
33. Soltesz G., Patterson C.C., and Dahlquist G. Worldwide childhood type 1 diabetes incidence-what can we learn from epidemiology?. Pediatr. Diabetes 8 Suppl 6 (2007) 6-14
34. Levy-Marchal C., Patterson C., and Green A. Variation by age group and seasonality at diagnosis of childhood IDDM in Europe. The EURODIAB ACE study group. Diabetologia 38 (1995) 823-830
35. Pundziute-Lycka A., Dahlquist G., Nystrom L., Arnqvist H., Bjork E., Blohme G., Bolinder J., Eriksson J.W., Sundkvist G., and Ostman J. The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-1998. Diabetologia 45 (2002) 783-791
36. Chapter One: Diabetes in children: epidemiology. Pediatr. Diabetes 8 (2007) 10-18.
37. Gardner S.G., Bingley P.J., Sawtell P.A., Weeks S., and Gale E.A. Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. Br. Med. J. 315 (1997) 713-717
38. Karvonen M., Pitkaniemi J., and Tuomilehto J. The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group. Diabetes Care 22 (1999) 1066-1070
39. Schoenle E.J., Lang-Muritano M., Gschwend S., Laimbacher J., Mullis P.E., Torresani T., Biason-Lauber A., and Molinari L. Epidemiology of type I diabetes mellitus in Switzerland: steep rise in incidence in under 5 year old children in the past decade. Diabetologia 44 (2001) 286-289
40. Jarosz-Chobot P., Otto-Buczkowska E., Koehler B., Matlakiewicz E., and Green A. Increased trend of type 1 diabetes mellitus in children's population (0-14 years) in Upper Silesia region (Poland). Med. Sci. Monit. 6 (2000) 573-580
41. Krolewski A.S., Warram J.H., Rand L.I., and Kahn C.R. Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N. Engl. J. Med. 317 (1987) 1390-1398
42. Onkamo P., Väänänem S., Karvonen M., and Tuomilehto J. Worldwide increase in incidence of Type I diabetes - the analysis of the data on published incidence trends. Diabetologia 42 (1999) 1395-1403
43. Patterson C.C., Carson D.J., and Hadden D.R. Epidemiology of childhood IDDM in Northern Ireland 1989-1994: low incidence in areas with highest population density and most household crowding. Northern Ireland Diabetes Study Group. Diabetologia 39 (1996) 1063-1069
44. Harjutsalo V., Sj L., berg, and Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 371 (2008) 1777-1782
45. Lammi N., Blomstedt P., Moltchanova E., Eriksson J., Tuomilehto J., and Karvonen M. Marked temporal increase in the incidence of type 1 and type 2 diabetes among young adults in Finland. Diabetologia 51 (2008) 897-899
46. Lipman T.H., Chang Y., and Murphy K.M. The epidemiology of type 1 diabetes in children in Philadelphia 1990-1994: evidence of an epidemic. Diabetes Care 25 (2002) 1969-1975
47. Lipman T.H., Jawad A.F., Murphy K.M., Tuttle A., Thompson R.L., Ratcliffe S.J., and Levitt Katz L.E. Incidence of Type 1 Diabetes in Philadelphia Is Higher in Black Than White Children From 1995 to 1999: Epidemic or misclassification?. Diabetes Care 29 (2006) 2391-2395
48. Lipton R.B., and Fivecoate J.A. High risk of IDDM in African-American and Hispanic children in Chicago, 1985-1990. Diabetes Care 18 (1995) 476-482
49. Dokheel T.M. An epidemic of childhood diabetes in the United States? Evidence from Allegheny County, Pennsylvania. Pittsburgh Diabetes Epidemiology Research Group. Diabetes Care 16 (1993) 1606-1611
50. Cardwell C., Carson D., and Patterson C. Higher incidence of childhood-onset type 1 diabetes mellitus in remote areas: a UK regional small-area analysis. Diabetologia 49 (2006) 2074-2077
51. Sadeharju K., Knip M., Virtanen S.M., Savilahti E., Tauriainen S., Koskela P., Akerblom H.K., and Hyoty H. Maternal antibodies in breast milk protect the child from enterovirus infections. Pediatrics 119 (2007) 941-946
52. Dahlquist G., and Kallen B. Maternal-child blood group incompatibility and other perinatal events increase the risk for early-onset type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35 (1992) 671-675
53. McKinney P.A., Parslow R., Gurney K., Law G., Bodansky H.J., and Williams D.R. Antenatal risk factors for childhood diabetes mellitus; a case-control study of medical record data in Yorkshire, UK. Diabetologia 40 (1997) 933-939
54. Wagener D.K., LaPorte R.E., Orchard T.J., Cavender D., Kuller L.H., and Drash A.L. The Pittsburgh diabetes mellitus study. 3: An increased prevalence with older maternal age. Diabetologia 25 (1983) 82-85
55. Akerblom H.K., Vaarala O., Hyoty H., Ilonen J., and Knip M. Environmental factors in the etiology of type 1 diabetes. Am. J. Med. Genet. 115 (2002) 18-29
56. Myers M.A., Mackay I.R., Rowley M.J., and Zimmet P.Z. Dietary microbial toxins and type 1 diabetes-a new meaning for seed and soil. Diabetologia 44 (2001) 1199-1200
57. Waldhor T., and Schober E. Regional distribution of risk for childhood diabetes in Austria and possible association with body mass index. Eur. J. Pediatr. 162 (2003) 380-384
58. Hyttinen V., Kaprio J., Kinnunen L., Koskenvuo M., and Tuomilehto J. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52 (2003) 1052-1055
59. Redondo M.J., Yu L., Hawa M., Mackenzie T., Pyke D.A., Eisenbarth G.S., and Leslie R.D. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44 (2001) 354-362
60. Sanjeevi C.B., DeWeese C., Landin-Olsson M., Kockum I., Dahlquist G., Lernmark A., and Lybrand T.P. Analysis of critical residues of HLA-DQ6 molecules in insulin-dependent diabetes mellitus. Tissue Antigens 50 (1997) 61-65
61. Jahromi M.M., and Eisenbarth G.S. Genetic determinants of type 1 diabetes across populations. Ann. N.Y. Acad. Sci. 1079 (2006) 289-299
62. Ikegami H., Fujisawa T., Kawabata Y., Noso S., and Ogihara T. Genetics of type 1 diabetes: similarities and differences between asian and caucasian populations. Ann. N.Y. Acad. Sci. 1079 (2006) 51-59
63. Aly T.A., Ide A., Jahromi M.M., Barker J.M., Fernando M.S., Babu S.R., Yu L., Miao D., Erlich H.A., Fain P.R., Barriga K.J., Norris J.M., Rewers M.J., and Eisenbarth G.S. Extreme genetic risk for type 1A diabetes. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 14074-14079
64. Kawabata Y., Ikegami H., Kawaguchi Y., Fujisawa T., Shintani M., Ono M., Nishino M., Uchigata Y., Lee I., and Ogihara T. Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 51 (2002) 545-551
65. Bottini N., Musumeci L., Alonso A., Rahmouni S., Nika K., Rostamkhani M., MacMurray J., Meloni G.F., Lucarelli P., Pellecchia M., Eisenbarth G.S., Comings D., and Mustelin T. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36 (2004) 337-338
66. Concannon P., Erlich H.A., Julier C., Morahan G., Nerup J., Pociot F., Todd J.A., Rich S.S., and the T. Type 1 diabetes: evidence for susceptibility loci from four genome-wide linkage scans in 1,435 multiplex families. Diabetes 54 (2005) 2995-3001
67. Smyth D., Cooper J.D., Collins J.E., Heward J.M., Franklyn J.A., Howson J.M.M., Vella A., Nutland S., Rance H.E., Maier L., Barratt B.J., Guja C., Ionescu-Tirgoviste C., Savage D.A., Dunger D.B., Widmer B., Strachan D.P., Ring S.M., Walker N., Clayton D.G., Twells R.C.J., Gough S.C.L., and Todd J.A. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 53 (2004) 3020-3023
68. Ueda H., Howson J.M.M., Esposito L., Heward J., Snook, Chamberlain G., Rainbow D.B., Hunter K.M.D., Smith A.N., Di Genova G., Herr M.H., Dahlman I., Payne F., Smyth D., Lowe C., Twells R.C.J., Howlett S., Healy B., Nutland S., Rance H.E., Everett V., Smink L.J., Lam A.C., Cordell H.J., Walker N.M., Bordin C., Hulme J., Motzo C., Cucca F., Hess J.F., Metzker M.L., Rogers J., Gregory S., Allahabadia A., Nithiyananthan R., Tuomilehto-Wolf E., Tuomilehto J., Bingley P., Gillespie K.M., Undlien D.E., Ronningen K.S., Guja C., Ionescu-Tirgoviste C., Savage D.A., Maxwell A.P., Carson D.J., Patterson C.C., Franklyn J.A., Clayton D.G., Peterson L.B., Wicker L.S., Todd J.A., and Gough S.C.L. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 (2003) 506-511
69. Baschal E.E., and Eisenbarth G.S. Extreme genetic risk for type 1A diabetes in the post-genome era. J. Autoimmun. 31 (2008) 1-6
70. Spielman R.S., McGinnis R.E., and Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52 (1993) 506-516
71. Nakayama M., Abiru N., Moriyama H., Babaya N., Liu E., Miao D., Yu L., Wegmann D.R., Hutton J.C., Elliott J.F., and Eisenbarth G.S. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435 (2005) 220-223
72. Zheng W., and She J.X. Genetic association between a lymphoid tyrosine phosphatase (PTPN22) and type 1 diabetes. Diabetes 54 (2005) 906-908
73. Smyth D.J., Cooper J.D., Bailey R., Field S., Burren O., Smink L.J., Guja C., Ionescu-Tirgoviste C., Widmer B., Dunger D.B., Savage D.A., Walker N.M., Clayton D.G., and Todd J.A. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet. 38 (2006) 617-619
74. Feltbower R.G., Bodansky H.J., McKinney P.A., Houghton J., Stephenson C.R., and Haigh D. Trends in the incidence of childhood diabetes in south Asians and other children in Bradford, UK. Diabet. Med. 19 (2002) 162-166
75. Raymond N.T., Jones J.R., Swift P.G.F., Davies M.J., Lawrence I.G., McNally P.G., Burden M.L., Gregory R., Botha J.L., and Burden A.C. Comparative incidence of Type I diabetes in children aged under 15 years from South Asian and white or other ethnic backgrounds in Leicestershire, UK, 1989 to 1998. Diabetologia 44 (2001) B32-B36
76. Muntoni S., Fonte M.T., Stoduto S., Marietti G., Bizzarri C., Crino A., Ciampalini P., Multari G., Suppa M.A., Matteoli M.C., Lucentini L., Sebastiani L.M., Visalli N., Pozzilli P., Boscherini B., and Muntoni S. Incidence of insulin-dependent diabetes mellitus among Sardinian-heritage children born in Lazio region, Italy. Lancet 349 (1997) 160-162
77. Hjern A., and Soderstrom U. Parental country of birth is a major determinant of childhood type 1 diabetes in Sweden. Pediatr. Diabetes 9 (2008) 35-39
78. Kolb H., and Elliott R.B. Increasing incidence of IDDM a consequence of improved hygiene?. Diabetologia 37 (1994) 729
79. Kilkkinen A., Virtanen S.M., Klaukka T., Kenward M.G., Salkinoja-Salonen M., Gissler M., Kaila M., and Reunanen A. Use of antimicrobials and risk of type 1 diabetes in a population-based mother-child cohort. Diabetologia 49 (2006) 66-70
80. Gibbon C., Smith T., Egger P., Betts P., and Phillips D. Early infection and subsequent insulin dependent diabetes. Arch. Dis. Child. 77 (1997) 384-385
81. Pundziute-Lyckå A., Urbonait-ù B., and Dahlquist G. Infections and risk of Type I (insulin-dependent) diabetes mellitus in Lithuanian children. Diabetologia 43 (2000) 1229-1234
82. Viskari H., Ludvigsson J., Uibo R., Salur L., Marciulionyte D., Hermann R., Soltesz G., Fuchtenbusch M., Ziegler A.G., Kondrashova A., Romanov A., Kaplan B., Laron Z., Koskela P., Vesikari T., Huhtala H., Knip M., and Hyoty H. Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia 48 (2005) 1280-1287
83. Infections and vaccinations as risk factors for childhood type I (insulin-dependent) diabetes mellitus: a multicentre case-control investigation. EURODIAB Substudy 2 Study Group. Diabetologia 43 (2000) 47-53.
84. Cardwell C.R., Carson D.J., and Patterson C.C. No association between routinely recorded infections in early life and subsequent risk of childhood-onset Type 1 diabetes: a matched case-control study using the UK General Practice Research Database. Diabet. Med. 25 (2008) 261-267
85. Christen U., and von Herrath M.G. Infections and autoimmunity-good or bad?. J. Immunol. 174 (2005) 7481-7486
86. Jaeckel E., Manns M., and von Herrath M. Viruses and diabetes. Ann. N.Y. Acad. Sci. 958 (2002) 7-25
87. Dotta F., Censini S., van Halteren A.G.S., Marselli L., Masini M., Dionisi S., Mosca F., Boggi U., Muda A.O., Prato S.D., Elliott J.F., Covacci A., Rappuoli R., Roep B.O., and Marchetti P. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 5115-5120
88. King M.L., Shaikh A., Bidwell D., Voller A., and Banatvala J.E. Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus. Lancet 1 (1983) 1397-1399
89. King M.L., Bidwell D., Voller A., Bryant J., and Banatvala J.E. Role of Coxsackie B viruses in insulin-dependent diabetes mellitus. Lancet 2 (1983) 915-916
90. Szopa T.M., Titchener P.A., Portwood N.D., and Taylor K.W. Diabetes mellitus due to viruses-some recent developments. Diabetologia 36 (1993) 687-695
91. Banatvala J.E., Bryant J., Schernthaner G., Borkenstein M., Schober E., Brown D., De Silva L.M., Menser M.A., and Silink M. Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet 1 (1985) 1409-1412
92. Zipris D., Hillebrands J.L., Welsh R.M., Rozing J., Xie J.X., Mordes J.P., Greiner D.L., and Rossini A.A. Infections that induce autoimmune diabetes in BBDR rats modulate CD4+CD25+ T cell populations. J. Immunol. 170 (2003) 3592-3602
93. Zipris D., Lien E., Xie J.X., Greiner D.L., Mordes J.P., and Rossini A.A. TLR activation synergizes with Kilham rat virus infection to induce diabetes in BBDR rats. J. Immunol. 174 (2005) 131-142
94. Zipris D., Lien E., Nair A., Xie J.X., Greiner D.L., Mordes J.P., and Rossini A.A. TLR9-signaling pathways are involved in Kilham rat virus-induced autoimmune diabetes in the biobreeding diabetes-resistant rat. J. Immunol. 178 (2007) 693-701
95. von Herrath M.G. Regulation of virally induced autoimmunity and immunopathology: contribution of LCMV transgenic models to understanding autoimmune insulin-dependent diabetes mellitus. Curr. Top. Microbiol. Immunol. 263 (2002) 145-175
96. Jun H.S., and Yoon J.W. A new took at viruses in type 1 diabetes. Diabetes/Metab. Res. Rev. 19 (2003) 8-31
97. Ginsberg-Fellner F., Witt M.E., Yagihashi S., Dobersen M.J., Taub F., Fedun B., McEvoy R.C., Roman S.H., Davies R.G., and Cooper L.Z. Congenital rubella syndrome as a model for type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Diabetologia 27 Suppl (1984) 87-89
98. Hyoty H., Leinikki P., REUNANEN A., Ilonen J., Surcel H.M., Rilva A., Kaar M.L., Huupponen T., Hakulinen A., and Makela A.L. Mumps infections in the etiology of type 1 (insulin-dependent) diabetes. Diabetes Res. 9 (1988) 111-116
99. Hiltunen M., Hyoty H., Karjalainen J., Leinikki P., Knip M., Lounamaa R., and Akerblom H.K. Serological evaluation of the role of cytomegalovirus in the pathogenesis of IDDM: a prospective study. The Childhood Diabetes in Finland study group. Diabetologia 38 (1995) 705-710
100. Pak C.Y., Eun H.M., McArthur R.G., and Yoon J.W. Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 2 (1988) 1-4
101. Surcel H.M., Karttunen R., Ilonen J., and Kaar M.L. Lymphocyte responsiveness and interleukin 2 production in type 1 (insulin-dependent) diabetes mellitus. J. Clin. Lab. Immunol. 22 (1987) 163-164
102. Chikazawa K., Okusa H., Minakami H., Kimura K., Araki S., and Tamada T. [Acute onset of insulin-dependent diabetes mellitus caused by Epstein-Barr virus infection]. Nippon Sanka Fujinka Gakkai Zasshi 37 (1985) 453-456
103. Jali M.V., and Shankar P.S. Transient diabetes following chicken pox. J. Assoc. Phys. India 38 (1990) 663-664
104. Honeyman M.C., Coulson B.S., Stone N.L., Gellert S.A., Goldwater P.N., Steele C.E., Couper J.J., Tait B.D., Colman P.G., and Harrison L.C. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 49 (2000) 1319-1324
105. Rewers M., LaPorte R.E., Walczak M., Dmochowski K., and Bogaczynska E. Apparent epidemic of insulin-dependent diabetes mellitus in Midwestern Poland. Diabetes 36 (1987) 106-113
106. Knip M., Veijola R., Virtanen S.M., Hyoty H., Vaarala O., and Akerblom H.K. Environmental triggers and determinants of type 1 diabetes. Diabetes 54 (2005) S125-S136
107. Andreoletti L., Hober D., Hober-Vandenberghe C., Fajardy I., Belaich S., Lambert V., Vantyghem M.C., Lefebvre J., and Wattre P. Coxsackie B virus infection and [beta] cell autoantibodies in newly diagnosed IDDM adult patients. Clin. Diagn. Virol. 9 (1998) 125-133
108. Chehadeh W., Weill J., Vantyghem M.-C., Alm G., Lefebvre J., Wattre P., and Hober D. Increased level of interferon-α in blood of patients with insulin-dependent diabetes mellitus: relationship with Coxsackievirus B infection. J. Infect. Dis. 181 (2000) 1929-1939
109. Juhela S., Hyoty H., Roivainen M., Harkonen T., Putto-Laurila A., Simell O., and Ilonen J. T-cell responses to enterovirus antigens in children with type 1 diabetes. Diabetes 49 (2000) 1308-1313
110. Nairn C., Galbraith D.N., Taylor K.W., and Clements G.B. Enterovirus variants in the serum of children at the onset of Type 1 diabetes mellitus. Diabet. Med. 16 (1999) 509-513
111. Sadeharju K., Lonnrot M., Kimpimaki T., Savola K., Erkkila S., Kalliokoski T., Savolainen P., Koskela P., Ilonen J., Simell O., Knip M., and Hyoty H. Enterovirus antibody levels during the first two years of life in prediabetic autoantibody-positive children. Diabetologia 44 (2001) 818-823
112. Lonnrot M., Korpela K., Knip M., Ilonen J., Simell O., Korhonen S., Savola K., Muona P., Simell T., Koskela P., and Hyoty H. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention study. Diabetes 49 (2000) 1314-1318
113. Horwitz M.S., Ilic A., Fine C., Balasa B., and Sarvetnick N. Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells. Clin. Immunol. 110 (2004) 134-144
114. Hirahara K., Liu L., Clark R.A., Yamanaka K., Fuhlbrigge R.C., and Kupper T.S. The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J. Immunol. 177 (2006) 4488-4494
115. Maria H., Elshebani A., Anders O., Torsten T., and Gun F. Simultaneous type 1 diabetes onset in mother and son coincident with an enteroviral infection. J. Clin. Virol. 33 (2005) 158-167
116. Yoon J.W., Austin M., Onodera T., and Notkins A.L. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N. Engl. J. Med. 300 (1979) 1173-1179
117. Champsaur H.F., Bottazzo G.F., Bertrams J., Assan R., and Bach C. Virologic, immunologic, and genetic factors in insulin-dependent diabetes mellitus. J. Pediatr. 100 (1982) 15-20
118. Yoon J.W., and Jun H.S. Viruses in type 1 diabetes: brief review. ILAR J. 45 (2004) 343-348
119. Fuchtenbusch M., Irnstetter A., Jager G., and Ziegler A.-G. No evidence for an association of Coxsackie virus infections during pregnancy and early childhood with development of islet autoantibodies in offspring of mothers or fathers with type 1 diabetes. J. Autoimmun. 17 (2001) 333-340
120. Foulis A.K., Farquharson M.A., Cameron S.O., McGill M., Schonke H., and Kandolf R. A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis. Diabetologia 33 (1990) 290-298
121. Graves P.M., Rotbart H.A., Nix W.A., Pallansch M.A., Erlich H.A., Norris J.M., Hoffman M., Eisenbarth G.S., and Rewers M. Prospective study of enteroviral infections and development of beta-cell autoimmunity: Diabetes Autoimmunity Study in the Young (DAISY). Diabetes Res. Clin. Pract. 59 (2003) 51-61
122. Noble J.A., Valdes A.M., Cook M., Klitz W., Thomson G., and Erlich H.A. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am. J. Hum. Genet. 59 (1996) 1134-1148
123. Lambert A.P., Gillespie K.M., Thomson G., Cordell H.J., Todd J.A., Gale E.A.M., and Bingley P.J. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J. Clin. Endocrinol. Metab. 89 (2004) 4037-4043
124. Berka N., Bland G.N., Gause D.P., Harris P.F., Erabhaoui E.H., Bonar A.S., and Dunston G.M. Early age of disease onset in African American type 1 diabetes patients is associated with DQB1*0201 allele. Hum. Immunol. 61 (2000) 816-819
125. Buzzetti R., Quattrocchi C.C., and Nistico L. Dissecting the genetics of type 1 diabetes: relevance for familial clustering and differences in incidence. Diabetes/Metab. Rev. 14 (1998) 111-128
126. Nejentsev S., Howson J.M.M., Walker N.M., Szeszko J., Field S.F., Stevens H.E., Reynolds P., Hardy M., King E., Masters J., Hulme J., Maier L.M., Smyth D., Bailey R., Cooper J.D., Ribas G., Campbell R.D., Clayton D.G., and Todd J.A. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450 (2007) 887-892
127. Joner G., and Sovik O. Increasing incidence of diabetes mellitus in Norwegian children 0-14 years of age 1973-1982. Diabetologia 32 (1989) 79-83
128. Karvonen M., Jantti V., Muntoni S., Stabilini M., Stabilini L., Muntoni S., and Tuomilehto J. Comparison of the seasonal pattern in the clinical onset of IDDM in Finland and Sardinia. Diabetes Care 21 (1998) 1101-1109
129. Glatthaar C., Whittall D.E., Welborn T.A., Gibson M.J., Brooks B.H., Ryan M.M., and Byrne G.C. Diabetes in Western Australian children: descriptive epidemiology. Med. J. Aust. 148 (1988) 117-123
130. Dahlquist G., Blom L., Holmgren G., Hagglof B., Larsson Y., Sterky G., and Wall S. The epidemiology of diabetes in Swedish children 0-14 years-a six-year prospective study. Diabetologia 28 (1985) 802-808
131. Weets I., Kaufman L., Van der A.B., Crenier L., Rooman R.P., De Block C., Casteels K., Weber E., Coeckelberghs M., Laron Z., Pipeleers D.G., and Gorus F.K. Seasonality in clinical onset of type 1 diabetes in belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence. Diabetologia 47 (2004) 614-621
132. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20 (2002) 197-216
133. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 449 (2007) 819-826
134. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
135. Meylan E., Tschopp J., and Karin M. Intracellular pattern recognition receptors in the host response. Nature 442 (2006) 39-44
136. Sansonetti P.J. The innate signaling of dangers and the dangers of innate signaling. Nat. Immunol. 7 (2006) 1237-1242
137. Anderson M.S., and Bluestone J.A. The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23 (2005) 447-485
138. Serreze D.V., Ottendorfer E.W., Ellis T.M., Gauntt C.J., and Atkinson M.A. Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 49 (2000) 708-711
139. Tracy S., and Drescher K.M. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes. Ann. N.Y. Acad. Sci. 1103 (2007) 143-151
140. Berg A.K., Korsgren O., and Frisk G. Induction of the chemokine interferon-+|-inducible protein-10 in human pancreatic islets during enterovirus infection. Diabetologia 49 (2006) 2697-2703
141. Zanone M.M., Favaro E., Ferioli E., Huang G.C., Klein N.J., Perin P.C., Peakman M., Conaldi P.G., and Camussi G. Human pancreatic islet endothelial cells express coxsackievirus and adenovirus receptor and are activated by coxsackie B virus infection. FASEB J. 21 (2007) 3308-3317
142. Triantafilou K., Orthopoulos G., Vakakis E., Ahmed M.A.E., Golenbock D.T., Lepper P.M., and Triantafilou M. Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell. Microbiol. 7 (2005) 1117-1126
143. Horwitz M.S., Bradley L.M., Harbertson J., Krahl T., Lee J., and Sarvetnick N. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4 (1998) 781-785
144. Ylipaasto P., Klingel K., Lindberg A.M., Otonkoski T., Kandolf R., Hovi T., and Roivainen M. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 47 (2004) 225-239
145. Kim H.S., Han M.S., Chung K.W., Kim S., Kim E., Kim M.J., Jang E., Lee H.A., Youn J., Akira S., and Lee M.S. Toll-like receptor 2 senses [beta]-cell death and contributes to the initiation of autoimmune diabetes. Immunity 27 (2007) 321-333
146. Sutmuller R.P., den Brok M.H., Kramer M., Bennink E.J., Toonen L.W., and Kullberg B.J. Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116 (2006) 485-494
147. Zanin-Zhorov A., Cahalon L., Tal G., Margalit R., Lider O., and Cohen I.R. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J. Clin. Invest. 116 (2006) 2022-2032
148. Filippi C.M., and von Herrath M.G. Islet [beta]-cell death- fuel to sustain autoimmunity?. Immunity 27 (2007) 183-185
149. Wen L., Peng J., Li Z., and Wong F.S. The effect of innate immunity on autoimmune diabetes and the expression of Toll-like receptors on pancreatic islets. J. Immunol. 172 (2004) 3173-3180
150. Ohashi P.S., Oehen S., Buerki K., Pircher H., Ohashi C.T., Odermatt B., Malissen B., Zinkernagel R.M., and Hengartner H. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65 (1991) 305-317
151. Lang K.S., Recher M., Junt T., Navarini A.A., Harris N.L., Freigang S., Odermatt B., Conrad C., Ittner L.M., Bauer S., Luther S.A., Uematsu S., Akira S., Hengartner H., and Zinkernagel R.M. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat. Med. 11 (2005) 138-145
152. Greiner D.L., Rossini A.A., and Mordes J.P. Translating data from animal models into methods for preventing human autoimmune diabetes mellitus: caveat emptor and primum non nocere. Clin. Immunol. 100 (2001) 134-143
153. Ellerman K.E., Richards C.A., Guberski D.L., Shek W.R., and Like A.A. Kilham rat triggers T-cell-dependent autoimmune diabetes in multiple strains of rat. Diabetes 45 (1996) 557-562
154. Jacoby R.O., Ball-Goodrich L.J., Besselsen D.G., McKisic M.D., Riley L.K., and Smith A.L. Rodent parvovirus infections. Lab. Anim. Sci. 46 (1996) 370-380
155. Takasawa N., Munakata Y., Ishii K.K., Takahashi Y., Takahashi M., Fu Y., Ishii T., Fujii H., Saito T., Takano H., Noda T., Suzuki M., Nose M., Zolla-Patzner S., and Sasaki T. Human parvovirus B19 transgenic mice become susceptible to polyarthritis. J. Immunol. 173 (2004) 4675-4683
156. Guberski D.L., Thomas V.A., Shek W.R., Like A.A., Handler E.S., Rossini A.A., Wallace J.E., and Welsh R.M. Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science 254 (1991) 1010-1013
157. Chung Y.H., Jun H.S., Son M., Bao M., Bae H.Y., Kang Y., and Yoon J.W. Cellular and molecular mechanism for Kilham rat virus-induced autoimmune diabetes in DR-BB rats. J. Immunol. 165 (2000) 2866-2876
158. Kaizer E.C., Glaser C.L., Chaussabel D., Banchereau J., Pascual V., and White P.C. Gene expression in peripheral blood mononuclear cells from children with diabetes. J. Clin. Endocrinol. Metab. 92 (2007) 3705-3711
159. Wang X., Jia S., Geoffrey R., Alemzadeh R., Ghosh S., and Hessner M.J. Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. J. Immunol. 180 (2008) 1929-1937
160. Triantafilou K., and Triantafilou M. Coxsackievirus B4-Induced Cytokine Production in Pancreatic Cells Is Mediated through Toll-Like Receptor 4. J. Virol. 78 (2004) 11313-11320
161. Christen U., Benke D., Wolfe T., Rodrigo E., Rhode A., Hughes A.C., Oldstone M.B., and von Herrath M.G. Cure of prediabetic mice by viral infections involves lymphocyte recruitment along an IP-10 gradient. J. Clin. Invest. 113 (2004) 74-84
162. Oldstone M.B. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science 239 (1988) 500-502
163. Oldstone M.B. Viruses as therapeutic agents. I. Treatment of nonobese insulin-dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence. J. Exp. Med. 171 (1990) 2077-2089
164. Smith K.A., Efstathiou S., and Cooke A. Murine Gammaherpesvirus-68 Infection Alters Self-Antigen Presentation and Type 1 Diabetes Onset in NOD Mice. J. Immunol. 179 (2007) 7325-7333
165. van der W.N., Hillebrands J.L., Klatter F.A., Bos I., Bruggeman C.A., and Rozing J. Cytomegalovirus infection modulates cellular immunity in an experimental model for autoimmune diabetes. Clin. Dev. Immunol. 10 (2003) 153-160
166. Mordes J.P., Guberski D.L., Leif J.H., Woda B.A., Flanagan J.F., Greiner D.L., Kislauskis E.H., and Tirabassi R.S. LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation. Diabetes 54 (2005) 2727-2733
167. Ehehalt S., Blumenstock G., Willasch A.M., Hub R., Ranke M.B., and Neu A. Continuous rise in incidence of childhood Type 1 diabetes in Germany. Diabet. Med. 25 (2008) 755-757
168. Cinek O., Sumnik Z., and Vavrinec J. Continuing increase in incidence of childhood-onset type 1 diabetes in the Czech Republic 1990-2001. Eur. J. Pediatr. 162 (2003) 428-429
169. Charkaluk M.L., Czernichow P., and Levy-Marchal C. Incidence data of childhood-onset type I diabetes in France during 1988-1997: the case for a shift toward younger age at onset. Pediatr. Res. 52 (2002) 859-862
170. Casu A., Pascutto C., Bernardinelli L., and Songini M. Type 1 Diabetes Among Sardinian Children Is Increasing: The Sardinian diabetes register for children aged 0-14 years (1989-1999). Diabetes Care 27 (2004) 1623-1629
171. Svensson J., Carstensen B., Molbak A., Christau B., Mortensen H.B., Nerup J., and Borch-Johnsen K. Increased risk of childhood type 1 diabetes in children born after 1985. Diabetes Care 25 (2002) 2197-2201